Physician profile
Ashley H Ware
NPI 1386907970
$8,915.47
in general payments reported to CMS, 2019-2025
23 companies · $846 in 2025
The $846 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,574 · 2020: $1,621 · 2021: $892 · 2022: $1,358 · 2023: $946 · 2024: $679 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,452 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,452.34 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,852.64 | 2019-2025 | Total30, Rocklatan, Dailies Total1 |
| Kala Pharmaceuticals, INC. | $1,889.32 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $960.70 | 2020-2025 | Cequa |
| Allergan, INC. | $957.98 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $548.26 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $436.67 | 2019-2021 | |
| Abbvie INC. | $373.34 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Novartis Pharmaceuticals Corporation | $174.16 | 2019-2023 | |
| Glaukos Corporation | $149.48 | 2022 | |
| Harrow Eye, LLC | $78.33 | 2025 | Vevye |
| Oyster Point Pharma, INC. | $76.79 | 2022-2023 | Tyrvaya |
| Biotissue Holdings INC. | $66.04 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $52.12 | 2019-2021 | |
| Dompe US, INC. | $49.22 | 2022-2024 | Oxervate |
| Akorn, INC. | $41.35 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $38.66 | 2025 | Iyuzeh |
| Rxsight INC | $35.48 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Heidelberg Engineering, INC. | $26.98 | 2020 | |
| Sight Sciences, INC. | $24.98 | 2023 | Tearcare System |
| Akorn Operating Company LLC | $24.60 | 2021 | |
| Shire North American Group INC | $21.77 | 2019 | |
| Alcon Research LLC | $18.82 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $17.78 | 2023 | Acuvue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Ware listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.